StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Tuesday. The firm issued a hold rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of NYSE MLSS opened at $1.02 on Tuesday. The company has a market cap of $79.45 million, a price-to-earnings ratio of -14.57 and a beta of 1.08. The stock’s 50-day moving average is $0.83 and its two-hundred day moving average is $0.84. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Insider Buying and Selling

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last quarter, insiders sold 109,193 shares of company stock worth $101,634. Corporate insiders own 24.75% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. World Investment Advisors LLC purchased a new stake in Milestone Scientific during the third quarter worth approximately $91,000. Geode Capital Management LLC raised its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $48,000. 5.79% of the stock is owned by institutional investors and hedge funds.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.